Amid opioid concerns, FDA approves powerful painkiller

//Amid opioid concerns, FDA approves powerful painkiller

Amid opioid concerns, FDA approves powerful painkiller

AcelRx Pharmaceuticals Inc. won its first Food and Drug Administration approval Friday of a restricted-use opioid delivery system, but the nation's top drug regulator issued an atypical statement to assuage concerns about another highly addictive painkiller hitting the market. Redwood City-based AcelRx's (NASDAQ: ACRX) Dsuvia is a single tablet of the opioid sufentanil, pre-packaged inside a three-inch plastic applicator that lets medical staff deliver the drug under the tongue. It faced a tough…

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2018-11-05T21:57:15+00:00 November 5th, 2018|Healthcare|

About the Author: